Three different conditions, one word, and a very common dead end. Here is how to tell them apart, why they arrive in perimenopause, and what actually changes the picture.
Not all dark spots are the same. Melasma, solar lentigines, and post-inflammatory hyperpigmentation can look almost identical in the mirror, but they sit at different depths in the skin and respond to completely different things. If a product cleared one spot and did nothing for the next, you were most likely treating two different conditions. Knowing which is which is the difference between a routine that works and a year of frustration.
The question that started this
A woman wrote to us recently. She is in her fifties, fair-skinned, and has been outdoors and active her whole life. She has always worn moisturizer and foundation with sunscreen, so her skin is in good shape overall. But the dark spots bother her, and they keep arriving.
Her dermatologist told her most of it was an immune response. Over-the-counter products had not moved it in a year. And then came the detail that stopped us: a few years ago, a vitamin C serum cleared one large spot on her left cheek, the driver's-side cheek, in about a month. She was so impressed that she bought more for the other spots. On those, it did nothing.
She assumed the spots were the same because they looked the same. They were not. That is the whole story, and it is worth unpacking, because a great many women are living inside this exact confusion.
Three different things, one word
Most of us use "dark spots" or "age spots" as a catch-all. Clinically, three distinct processes account for nearly all of it.
| Melasma | Solar lentigines | Post-inflammatory hyperpigmentation | |
|---|---|---|---|
| What it looks like | Blotchy, symmetrical patches with soft edges | Discrete, well-defined round or oval spots | Flat marks left behind where something healed |
| Where it shows up | Cheeks, forehead, upper lip, jawline, usually both sides | Face, hands, chest, shoulders, anywhere with sun history | Wherever the inflammation was |
| What drives it | Hormonal shifts plus UV, visible light, and heat | Cumulative lifetime UV exposure | Acne, irritation, a reaction, a scratch |
| Who tends to get it | More common in medium to deeper skin tones, though it occurs in all | Anyone with sun history, appears earlier in fair skin | Anyone, more persistent in deeper tones |
| Depth | Epidermal, dermal, or mixed | Usually epidermal | Epidermal or dermal, depending on how deep the inflammation went |
| Behaviour | Recurs, flares with heat and light, stubborn | Stable, accumulates over decades | Fades over months if the trigger stops |
Read that last row again, because it is the answer to the vitamin C puzzle.
Why one spot cleared and the next one did not
Pigment sitting in the epidermis, the outer layer, is reachable. It turns over. Support that turnover, protect against the oxidative stress that keeps feeding it, and superficial pigment can genuinely become less visible.
Pigment that has dropped into the dermis is a different situation. It sits underneath the layer that renews itself. Topical products are working at a distance from it. This is why dermal pigment is so much more stubborn, and why the same serum can look remarkable on one mark and useless on another.
Two spots that look identical on the surface can be at completely different depths. You cannot tell by looking. What you can tell is by how they behave. Pigment that responds within four to eight weeks was shallow. Pigment that has not moved in a year is likely deeper, or is being actively re-triggered.
That last possibility matters more than people realise. A spot that never fades might not be stubborn. It might be getting re-made.
Why now? The perimenopause connection nobody mentions
Here is the part that rarely comes up in a dermatology appointment and almost never comes up in skincare marketing.
Melanocytes, the cells that produce pigment, carry estrogen and progesterone receptors. Immunohistochemical studies comparing melasma-affected skin to the healthy skin right beside it have found higher nuclear expression of estrogen receptor-beta and progesterone receptor in the lesional skin, and a separate analysis in women with melasma found significantly increased progesterone receptor expression in epidermal lesions. Pigment production is hormonally responsive. This is why melasma has historically been called the mask of pregnancy, why it is associated with oral contraceptives, and why it turns up with hormone therapy.
Perimenopause is not a smooth decline in estrogen. It is years of erratic swings, often with peaks higher than anything in your thirties, before the eventual drop. Pigment-producing cells sit inside that volatility.
At the same time, three other things are happening.
- Barrier function changes. Skin lipids decline. A compromised barrier inflames more easily, and inflammation drives pigment.
- Acne returns. Shifting androgen-to-estrogen ratios mean many women break out again in their late forties and fifties. Every one of those lesions can leave a mark. As our reader put it, perimenopause is adolescence in reverse.
- Antioxidant reserves thin out. The skin's own antioxidant capacity diminishes with age, so the same sun exposure produces more oxidative stress than it used to.
So a woman who spent forty years in the sun without much visible consequence can find that at 52 the spots arrive all at once. The sun history was always there. What changed is the hormonal environment it is now landing in, and the skin's reduced capacity to buffer it.
This is also why the "immune response" comment makes sense. Inflammation and pigment are linked. Inflammatory mediators stimulate melanocytes directly. If your skin is inflaming more easily than it used to, it is producing pigment more easily too.
What actually changes the picture
In order of impact, honestly ranked.
1. Daily broad-spectrum protection
Nothing else on this list matters as much. UV is the primary driver of solar lentigines and a major trigger for melasma. If you are working on pigment and not protecting daily, you are filling a bath with the plug out.
Visible light deserves a nuanced mention here, because it is frequently oversimplified in skincare content. The foundational study on this irradiated volunteers with either long-wavelength UVA or visible light and found that visible light produced pigmentation that was darker and longer-lasting than UVA1 in skin types IV to VI, while producing no pigmentation at all in skin type II. So if you have medium or deeper skin, or you have melasma, visible light protection is genuinely part of your strategy, and that means a tinted mineral sunscreen, because the iron oxides that provide the tint are what block visible light. If you are very fair, visible light is a smaller part of your picture than the internet suggests, and conventional broad-spectrum protection is doing most of the work.
The driver's-side cheek is a real phenomenon, incidentally. Car window glass filters UVB but transmits a substantial amount of UVA. Decades of commuting show up asymmetrically.
2. Stopping the re-trigger
If new pigment is being generated by acne, irritation, heat, or a barrier that is not holding, addressing that source does more than any brightening product will. This is the step most people skip, and it is often the one doing the most damage.
3. Antioxidant support
UV and visible light generate reactive oxygen species, and that oxidative stress is part of what signals melanocytes to produce pigment. A well-built antioxidant layer reduces that signalling load. This is supportive work rather than corrective work, and it is genuinely worth doing.
4. Gentle support for surface renewal
Encouraging the natural turnover of the outer layer helps superficial pigment become less visible over time. The word doing the heavy lifting is gentle, because aggressive exfoliation on pigment-prone skin frequently backfires. More inflammation means more pigment.
5. Prescription intervention where it is warranted
For established melasma, this is a conversation with a dermatologist. There are prescription routes that a cosmetic product is not a substitute for. We would rather tell you that than pretend otherwise.
Where the M-Veil Complex sits in this
Both M-Veil products, the Antioxidant Serum and the Resilience Balm, carry the same active stack in two different anhydrous formats. Here is what each part does in the context of uneven tone, and where the boundaries are.
We publish our use levels, which most brands do not. An ingredient list tells you what is in a bottle, not how much, and the gap between those two things is where a great deal of skincare marketing lives. A formula can name an impressive active and include it at a level that does nothing measurable. So alongside each number below is the reason it is that number, because a percentage without a rationale is just another marketing figure.
THDA (tetrahexyldecyl ascorbate), 2%
A lipid-soluble, oil-stable ester of vitamin C. Most vitamin C serums use L-ascorbic acid in water, which is unstable in aqueous solution and poorly absorbed, because at skin pH it is ionised and repelled by the lipophilic outer layer. That is why those formulas need a low pH that many sensitive skins do not tolerate. THDA is esterified with a branched fatty chain, which makes it stable above pH 5 and lets it move into the lipid environment of the stratum corneum rather than sitting on top of it. Comparative penetration work has found markedly better epidermal and dermal penetration for THD ascorbate than for L-ascorbic acid or sodium ascorbate.
Why 2%. Vitamin C esters are commonly used anywhere from a fraction of a percent to a few percent, and the low end of that range is frequently a label gesture rather than a working dose. Two percent sits well above that threshold while staying inside what an anhydrous system can carry without the ester crystallizing out over shelf life, and inside what sensitive skin reliably tolerates. Pushing higher would cost stability and comfort for diminishing return, particularly given that THDA's real limitation is not concentration but oxidation, which is addressed further down this list rather than by adding more of it.
Worth knowing if you have reacted to vitamin C before: this is a different molecule in a different vehicle. Not a guarantee, but a meaningful difference.
Bakuchiol, 0.5%
A plant-derived alternative to retinol that supports surface renewal without retinoid irritation. In a 12-week randomised, double-blind trial published in the British Journal of Dermatology, 0.5% bakuchiol and 0.5% retinol both significantly reduced wrinkle surface area and hyperpigmentation with no statistically significant difference between them, and the retinol group reported more scaling and stinging.
For pigment-prone skin, that tolerability difference matters more than it might seem. Retinoids work, but the irritation they cause can trigger the exact inflammatory pigment response you are trying to avoid.
Why 0.5%. This is the simplest number to justify in the whole formula, because it is the concentration used in the trial above. The study that made the case for bakuchiol tested it at 0.5%, so that is what we use. Formulating below a studied dose and then citing the study is a common sleight of hand, and we would rather match the evidence than borrow it.
Mushroom complex, 5%
Four adaptogenic extracts, reishi, chaga, cordyceps, and maitake, dissolved in oil. They contribute polyphenolic antioxidant activity and support skin that looks calm and comforted, which connects directly to the inflammation-and-pigment link above.
Why 5%. This is the upper end of the supplier's recommended use range for the complex, and going beyond it would not add activity, it would only add carrier oil and displace the lipids doing the barrier work. Five percent is the point where the extract contribution is maximised before the formula starts trading away something else.
CoQ10 1%, Vitamin E 1%, and Rosemary CO2 extract 0.3%
These three are not a list of bonus antioxidants. They form a network, and the network is the point.
An antioxidant works by donating an electron to a free radical. That neutralises the radical but leaves the antioxidant itself oxidised and spent. On its own, that is a single use. In combination, they regenerate one another. CoQ10 in its reduced form stabilises cell membranes against phospholipid peroxidation and regenerates oxidised vitamin C and vitamin E, so instead of each molecule firing once, the system keeps recycling.
This is not a marketing flourish. It addresses a real, published limitation of the star ingredient. A 2021 study found that THDA degrades rapidly when exposed to singlet oxygen and performs poorly as a standalone antioxidant, but that this degradation is prevented when it is paired with a stabilising co-antioxidant. In other words, vitamin C esters are not meant to work alone. Building a lipid-phase antioxidant network around THDA is not decoration, it is what allows the THDA to survive and do its job.
CoQ10 and vitamin E are both lipid-soluble and sit in the membrane environment where UV-driven lipid peroxidation actually happens. THDA, being esterified and lipophilic, sits there with them rather than in a water phase at a distance. Rosemary CO2 adds its own polyphenols and protects the oil phase itself from oxidation, which keeps the rest of the formula intact.
For uneven tone specifically, this matters because oxidative stress is part of the signalling cascade that tells melanocytes to produce pigment. Reducing that load is upstream work. It does not address pigment that is already there. It addresses the conditions that keep making more.
Why 1% CoQ10. CoQ10 is notoriously difficult to dissolve, and it will recrystallise out of a formula that has been pushed past what the oil phase can hold, leaving visible grit in the bottle. One percent is the ceiling our lipid system carries cleanly, confirmed by solubility trial rather than assumed. Many formulas list CoQ10 at a tenth of this because a tenth is easy. We went to the top of what the chemistry allows.
Why 1% vitamin E. This is the number that separates an antioxidant from a preservative. Tocopherol is routinely added to oil-based products at around 0.1 to 0.2% purely to stop the oils going rancid on the shelf, and that level does very little for your skin. At 1% it is doing two jobs: protecting the formula and functioning as a skin-facing antioxidant in its own right, at a level where it can hold up its end of the regeneration cycle with CoQ10 and THDA.
Why 0.3% rosemary CO2. Rosemary extract is a powerful protector of unsaturated oils, and this formula contains a lot of them. Below roughly 0.2% the protection thins out across a formula this unsaturated. Above roughly 0.4% the extract's own colour and aroma start asserting themselves, which matters particularly for our unscented variant. Three tenths of a percent is where protection is full and the extract stays invisible.
And the biomimetic lipid base
The actives sit in a base built to replenish the skin's own lipids, because a barrier that is holding properly inflames less, and less inflammation means less pigment signalling. The base is not a passenger here.
What this will not do
We are going to be direct, because you deserve a straight answer more than you deserve a sales pitch.
M-Veil is a cosmetic product. It is not a pigment treatment. It contains no hydroquinone, no tranexamic acid, no prescription actives. It will not erase established melasma, and it will not remove a dermal lentigo that has been sitting there for fifteen years.
It also contains no SPF. It is not a substitute for daily sun protection, and on the list above, sun protection outranks everything we make.
What it does is antioxidant and barrier work: reducing the oxidative and inflammatory load that drives new pigment formation, and supporting skin that looks brighter, calmer, and more even in tone. That is real, it is worth doing, and it is not the same thing as a treatment. Anyone telling you a serum will clear melasma is either misinformed or selling you something.
How to read a label for this
Worth looking for:
- A stable form of vitamin C. THDA, ascorbyl glucoside, and sodium ascorbyl phosphate are all more stable than L-ascorbic acid, particularly in anhydrous or low-water formats.
- Vitamin C supported by other antioxidants rather than standing alone. Given what the research says about ester degradation, a vitamin C product with no antioxidant partners is doing less than the label implies.
- A short, legible ingredient list where the actives appear high enough to be doing something.
- For daytime, a mineral sunscreen with iron oxides if you have melasma or medium to deeper skin.
Worth questioning:
- Any cosmetic promising to lighten, fade, bleach, or erase pigmentation. In Canada, claims of that kind fall on the drug side of the line rather than the cosmetic side. A cosmetic making them is over-claiming.
- Before-and-after photography without disclosed lighting, timeframe, and concurrent sun protection.
- A brightening product with no antioxidant support and no mention of sun protection. That is a product sold on hope.
If your skin is also acne-prone
Our reader asked a specific and smart question: are your products non-comedogenic, and will an oil serum break me out?
The honest answer is that "non-comedogenic" is an unregulated marketing term with no standardised test behind it. Any brand using it with total confidence is telling you more about their marketing than their testing.
What we can tell you is how the formula is built. M-Veil is anhydrous, meaning no water, and therefore no emulsifiers and no preservative system. Many people who break out from serums are reacting to emulsifiers or to film-forming agents in water-based formulas rather than to oil itself. The base is squalane-dominant, and squalane is a component of human sebum, which is part of why it tends to sit well on skin that does not tolerate heavier oils.
That is a reasoned explanation rather than a promise. Skin is individual. If you are acne-prone, patch test along your jawline for a week before going to full face.
One more note on format. If you are acne-prone and choosing between the two products, the serum is the better starting point. The balm is an occlusive overnight format built for very dry, depleted skin. Your instincts about texture are usually right.
Frequently asked questions
How do I know if I have melasma or sun spots?
Melasma appears as blotchy patches with soft, irregular edges, usually symmetrical across both cheeks or the forehead and upper lip. Solar lentigines are discrete, well-defined round spots. If you are not sure, a dermatologist can tell quickly, often using a Wood's lamp, which also indicates whether the pigment is epidermal or dermal. That depth information is genuinely useful, because it tells you what is realistically achievable.
Why did vitamin C clear one of my dark spots and not the others?
Most likely because the spots were at different depths, or because the ones that did not respond are being continuously re-triggered by sun, heat, or inflammation. Superficial epidermal pigment responds far more readily than dermal pigment.
Does menopause cause dark spots?
Hormonal fluctuation influences pigment production, because melanocytes carry estrogen and progesterone receptors, and studies have found higher expression of those receptors in melasma-affected skin. Perimenopause also brings barrier changes, a return of acne for many women, and reduced antioxidant reserves, all of which contribute to uneven-looking tone. Existing sun damage often becomes visible during this window rather than being newly created in it.
Can a serum remove melasma?
No cosmetic product can. Melasma is a chronic, recurring condition that usually requires a dermatologist-led approach combined with rigorous daily light protection. Cosmetic antioxidant support is a useful part of a broader strategy, not a treatment.
Will an oil-based serum break out acne-prone skin?
Not necessarily, and often not. Many people who break out from serums are reacting to emulsifiers or film-forming agents in water-based formulas rather than to lipids themselves. Anhydrous formulas contain neither. Patch test regardless.
Do I still need sunscreen if I already have dark spots?
Yes, and more than ever. Without daily broad-spectrum protection you are continuing to generate the thing you are trying to address. This is the single highest-impact step available to you.
Sources
- Dhaliwal S, Rybak I, Ellis SR, et al. Prospective, randomized, double-blind assessment of topical bakuchiol and retinol for facial photoageing. British Journal of Dermatology. 2019;180(2):289-296. doi:10.1111/bjd.16918
- Mahmoud BH, Ruvolo E, Hexsel CL, et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. Journal of Investigative Dermatology. 2010;130(8):2092-2097. doi:10.1038/jid.2010.95
- Tamega AA, Miot HA, Moço NP, et al. Gene and protein expression of oestrogen-beta and progesterone receptors in facial melasma and adjacent healthy skin in women. International Journal of Cosmetic Science. 2015;37(2):222-228. doi:10.1111/ics.12186
- Jang YH, Lee JY, Kang HY, Lee ES, Kim YC. Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis. Journal of the European Academy of Dermatology and Venereology. 2010;24(11):1312-1316. doi:10.1111/j.1468-3083.2010.03638.x
- Swindell WR, Randhawa M, Quijas G, Bojanowski K, Chaudhuri RK. Tetrahexyldecyl ascorbate (THDC) degrades rapidly under oxidative stress but can be stabilized by acetyl zingerone to enhance collagen production and antioxidant effects. International Journal of Molecular Sciences. 2021;22(16):8756. doi:10.3390/ijms22168756
- Maloney EM, et al. A closer look at penetration: the efficacy gap in vitamin C products. Journal of Cosmetic Dermatology. 2026. doi:10.1111/jocd.70851
- Zhang M, Dang L, Guo F, Wang X, Zhao W, Zhao R. The role of coenzyme Q10 in skin aging. Journal of Clinical and Aesthetic Dermatology.
- Cario M. How hormones may modulate human skin pigmentation in melasma: an in vitro perspective. Experimental Dermatology. 2019;28(6):709-718. doi:10.1111/exd.13915
This article is for general education and is not medical advice. If your dark spots are changing in size, shape, colour, or border, or if a single spot looks different from the others, have it examined by a physician. Persistent or worsening pigmentation is worth a dermatology referral.
Written by Barbi Marengo, founder of Philogeni Skincare and a certified cosmetic formulator with over twenty years of formulation experience. Philogeni makes clean, science-led skincare for women in perimenopause, menopause, and beyond.
With thanks
This piece exists because of an email. DK, a reader who wrote to us with a careful, specific set of questions about her own skin, asked better questions than most of what gets written on this subject. She wanted to know whether an oil would break her out, whether a serum could do anything for spots that had stopped responding, and whether she could have soft skin without a greasy finish under her foundation. Reasonable things to want, and surprisingly hard to get a straight answer about.
We answered her privately. Then we realized the answer was worth writing out properly, because if one woman is asking, a few thousand are wondering. DK, thank you for the question and for letting us build something out of it.
If you have one of your own, write to us. We read everything.